Infectious Diseases

Professor Azza Fahmy is a distinguished Egyptian parasitologist and senior academic at the Theodore Bilharz Research Institute, with a PhD in Comparative Physiology and a distinguished record of contributions to parasitic disease research, diagnostics, and experimental therapy. Her work has significantly advanced both laboratory and clinical approaches to parasitic infections, with a focus on novel therapeutics, smart diagnostics, and host-pathogen interactions. Professor Fahmy has authored numerous peer-reviewed publications covering a wide range of research themes, including: • Experimental therapies for schistosomiasis, trichinellosis, cryptosporidiosis, toxoplasmosis, and giardiasis using agents such as GABA, Lepidium sativum, Albendazole, Mefloquine, and Commiphora molmol. • Nanotechnology-based drug delivery systems in cancer therapy. • The role of the microbiome in human health, and the immunomodulatory effects of parasitic antigens. • Stem cell-based interventions for hepatic granuloma reversal in schistosomiasis models. • Evaluations of plant-derived antiparasitic compounds (e.g., Cyperus rotundus, Syzygium aromaticum). • Public health and policy-focused studies on antihypertensive medication adherence and its economic burden. • Pioneering reviews on AI applications in healthcare, including the early diagnosis of diabetic foot ulcers and chronic disease prediction. Her diagnostic innovations, such as antigen-based ELISAs, have improved the detection of various parasitic infections. She also engages in molecular diagnostics, immunopathology, and host-parasite interaction studies, enriching the field with both basic and translational insights. An active reviewer for several leading parasitology and biomedical journals, Professor Fahmy contributes to maintaining rigorous academic standards across disciplines. She is committed to professional development and global collaboration, frequently presenting at international symposia and fostering research partnerships.